GH
Guardant Health Inc
NASDAQ: GH · HEALTHCARE · DIAGNOSTICS & RESEARCH
$83.41
+0.39% today
Updated 2026-04-29
Market cap
$11.06B
P/E ratio
—
P/S ratio
11.26x
EPS (TTM)
$-3.32
Dividend yield
—
52W range
$36 – $121
Volume
2.0M
Guardant Health Inc (GH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-42.40%
Operating margin
-42.90%
ROE
-4,584.00%
ROA
-15.60%
Debt/equity
-3.74x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $25.25M | $-46.14M | 12.38% | -173.66% | -182.74% |
| 2017 | $49.84M | $-83.22M | 36.56% | -153.71% | -166.97% |
| 2018 | $90.64M | $-85.06M | 52.33% | -102.54% | -93.85% |
| 2019 | $214.38M | $-75.65M | 67.01% | -38.42% | -35.29% |
| 2020 | $286.73M | $-253.78M | 67.73% | -88.92% | -88.51% |
| 2021 | $373.65M | $-405.67M | 67.11% | -110.00% | -108.57% |
| 2022 | $449.54M | $-654.59M | 65.23% | -121.10% | -145.61% |
| 2023 | $563.95M | $-479.45M | 59.74% | -100.14% | -85.02% |
| 2024 | $739.02M | $-436.37M | 60.79% | -60.02% | -59.05% |
| 2025 | $982.02M | $-416.28M | 64.46% | -44.43% | -42.39% |